Calcipotriene Patent Expiration
Calcipotriene was first introduced by Leo Pharma As
Calcipotriene Patents
Given below is the list of patents protecting Calcipotriene, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Sorilux | US8263580 | Vitamin formulation | May 07, 2028 | Mayne Pharma |
| Sorilux | US8269128 | Vacuum switch tube | May 26, 2026 | Mayne Pharma |
| Sorilux | US8629128 | Vitamin formulation | May 26, 2026 | Mayne Pharma |
| Dovonex | US5763426 | Crystalline form of a vitamin D analogue |
Jun 09, 2015
(Expired) | Leo Pharm |
| Dovonex | US5763426 | Crystalline form of a vitamin D analogue |
Jun 09, 2015
(Expired) | Leo Pharma As |
| Dovonex | USRE39706 | Crystalline form of a vitamin D analogue |
Jun 09, 2015
(Expired) | Leo Pharm |
| Dovonex | USRE39706 | Crystalline form of a vitamin D analogue |
Jun 09, 2015
(Expired) | Leo Pharma As |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Calcipotriene's patents.
Latest Legal Activities on Calcipotriene's Patents
Given below is the list recent legal activities going on the following patents of Calcipotriene.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Yr, Small Entity | 04 Mar, 2024 | US8269128 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 21 Feb, 2024 | US8263580 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 23 Jun, 2021 | US8629128 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 16 Mar, 2020 | US8269128 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 18 Feb, 2020 | US8263580 |
| Recordation of Patent Grant Mailed Critical | 14 Jan, 2014 | US8629128 |
| Patent Issue Date Used in PTA Calculation Critical | 14 Jan, 2014 | US8629128 |
| Email Notification Critical | 25 Dec, 2013 | US8629128 |
| Issue Notification Mailed Critical | 24 Dec, 2013 | US8629128 |
| Dispatch to FDC | 18 Dec, 2013 | US8629128 |
Calcipotriene's Family Patents
Explore Our Curated Drug Screens
Calcipotriene Generic API Manufacturers
Several generic applications have been filed for Calcipotriene. The first generic version for Calcipotriene was by Fougera Pharmaceuticals Inc and was approved on May 6, 2008. And the latest generic version is by Chartwell Rx Sciences Llc and was approved on Dec 26, 2017.
Given below is the list of companies who have filed for Calcipotriene generic, along with the locations of their manufacturing plants worldwide.
1. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Calcipotriene. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.005% | solution | Prescription | TOPICAL | AT | Dec 26, 2017 |
2. COSETTE
Cosette Pharmaceuticals Inc has filed for 1 generic for Calcipotriene. Given below are the details of the strengths of this generic introduced by Cosette.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.005%
(reference standard) | solution | Prescription | TOPICAL | AT | Mar 24, 2011 |
Manufacturing Plant Locations New
Cosette's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Cosette as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
3. FOUGERA PHARMS
Fougera Pharmaceuticals Inc has filed for 1 generic for Calcipotriene. Given below are the details of the strengths of this generic introduced by Fougera Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.005% | solution | Prescription | TOPICAL | AT | May 6, 2008 |
4. GLENMARK PHARMS INC
Glenmark Pharmaceuticals Inc Usa has filed for 1 generic for Calcipotriene. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.005%
(reference standard) | ointment | Prescription | TOPICAL | AB | Mar 24, 2010 |
5. GLENMARK SPECLT
Glenmark Specialty Sa has filed for 1 generic for Calcipotriene. Given below are the details of the strengths of this generic introduced by Glenmark Speclt.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.005% | cream | Prescription | TOPICAL | AB | Jun 9, 2015 |
6. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Calcipotriene. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.005% | solution | Discontinued | TOPICAL | N/A | Nov 19, 2009 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| Portugal |
| |||||||||
| Jordan |
| |||||||||